Drugs / RG7342
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02196636 | Jul 2014 → Jan 2015 | — | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RG7342 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3545203 ↗ |
| Known as | RO6806127 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02196636 ↗ |
| Route | Oral | “Administered orally with approximately 240 mL of buffer” NCT02196636 ↗ |
| Target | GRM5 | “Metabotropic glutamate receptor 5 modulator” CHEMBL3545203 ↗ |